Bioinformatics aggregation predictors in the study of protein conformational diseases of the human nervous system

被引:6
作者
Guidolin, Diego [1 ]
Agnati, Luigi F. [2 ]
Albertin, Giovanna [1 ]
Tortorella, Cinzia [1 ]
Fuxe, Kjell [3 ]
机构
[1] Univ Padua, Dept Mol Med, I-35121 Padua, Italy
[2] IRCCS San Camillo, Lido VE, Venice, Italy
[3] Karolinska Inst, Dept Neurosci, Stockholm, Sweden
关键词
Amyloidoses; Neurodegenerative disease; Prediction software; ss-Propensity; Protein aggregation; AMYOTROPHIC-LATERAL-SCLEROSIS; AMYLOID FIBRIL FORMATION; RECEPTOR-RECEPTOR INTERACTIONS; ALZHEIMERS A-BETA-42 PEPTIDE; ALPHA-SYNUCLEIN; NEURODEGENERATIVE DISEASES; SEQUENCE DETERMINANTS; FORMING SEGMENTS; PRION PROTEIN; A-BETA;
D O I
10.1002/elps.201200290
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Conformational protein diseases of the human central nervous system represent a subject that has crucial theoretical and medical implications. They include several important neurodegenerative diseases, such as Alzheimer's, Parkinson's, Huntington's and Creutzfeldt-Jacob's diseases, amyotrophic lateral sclerosis, and the tauopathies. They occur when soluble proteins undergo conformational rearrangements becoming capable of aggregate into beta-sheets conformations leading to the production of insoluble complexes known as amyloid deposits, that accumulate and lead to neurons and glial cells death. Theoretical and experimental evidence indicates that a key role in the conformational changes leading to amyloid formation is played by short sequence stretches within a given protein. Thus, the identification of protein regions potentially involved in aggregate formation and the characterization of their properties are relevant questions in the study of conformational proteins diseases. To address these questions, bioinformatics methods might provide an important contribution, suggesting possible mechanisms of protein aggregation, and focusing and orienting the experimental work. Thus, in the first part of the present review bioinformatics methods specifically attempting to predict aggregation-prone regions in proteins will be briefly described. Furthermore, the results provided by the combined use of some of them to analyze a set of particularly important proteins involved in human degenerative diseases will be discussed.
引用
收藏
页码:3669 / 3679
页数:11
相关论文
共 90 条
[21]   Prion-like disorders: blurring the divide between transmissibility and infectivity [J].
Cushman, Mimi ;
Johnson, Brian S. ;
King, Oliver D. ;
Gitler, Aaron D. ;
Shorter, James .
JOURNAL OF CELL SCIENCE, 2010, 123 (08) :1191-1201
[22]   Mutagenesis of the central hydrophobic cluster in Aβ42 Alzheimer's pepticle -: Side-chain properties correlate with aggregation propensities [J].
de Groot, NS ;
Aviles, FX ;
Vendrell, J ;
Ventura, S .
FEBS JOURNAL, 2006, 273 (03) :658-668
[23]   Sequence determinants of amyloid fibril formation [J].
de la Paz, ML ;
Serrano, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (01) :87-92
[24]   Local environmental effects on the structure of the prion protein [J].
DeMarco, ML ;
Daggett, V .
COMPTES RENDUS BIOLOGIES, 2005, 328 (10-11) :847-862
[25]   VIROIDS AND PRIONS [J].
DIENER, TO ;
MCKINLEY, MP ;
PRUSINER, SB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (17) :5220-5224
[26]   Protein misfolding, evolution and disease [J].
Dobson, CM .
TRENDS IN BIOCHEMICAL SCIENCES, 1999, 24 (09) :329-332
[27]   A peptide motif consisting of glycine, alanine, and valine is required for the fibrillization and cytotoxicity of human α-synuclein [J].
Du, HN ;
Tang, L ;
Luo, XY ;
Li, HT ;
Hu, J ;
Zhou, JW ;
Hu, HY .
BIOCHEMISTRY, 2003, 42 (29) :8870-8878
[28]   Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains [J].
Dubay, KF ;
Pawar, AP ;
Chiti, F ;
Zurdo, J ;
Dobson, CM ;
Vendruscolo, M .
JOURNAL OF MOLECULAR BIOLOGY, 2004, 341 (05) :1317-1326
[29]   The Amyloid State of Proteins in Human Diseases [J].
Eisenberg, David ;
Jucker, Mathias .
CELL, 2012, 148 (06) :1188-1203
[30]  
El-Agnaf OMA, 2002, BIOCHEM SOC T, V30, P559